| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/06/2008 | US7368275 In vivo incorporation of unnatural amino acids |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2296364C Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050848A1 Adhesive preparation |
| 05/02/2008 | WO2008050836A1 Agent for ameliorating adverse side-effect of chemotherapeutic agent |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008049881A2 Polypeptides and pharmaceutical compositions comprising the same for the prevention and treatment of complications associated with infectious diseases |
| 05/02/2008 | WO2008049747A1 Novel heteroaryl carboxamides |
| 05/02/2008 | WO2008049595A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors |
| 05/02/2008 | CA2667536A1 Highly purified type a botulinum toxin preparation from infant botulism pathogen |
| 05/02/2008 | CA2667507A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 05/02/2008 | CA2666922A1 Novel heteroaryl carboxamides |
| 05/02/2008 | CA2664347A1 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 05/01/2008 | US20080103190 Thrombopoietin activity modulating compounds and methods |
| 05/01/2008 | US20080103152 7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-3,9-diazabicyclo [3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide; renin inhibitor; hypotensive agent, renal and cardial diseases, antidiabetic, antiinflammatory, anxiolitic agent, antidepressant |
| 05/01/2008 | US20080103143 3-{[(5-Chloro-thiophene-2-carbonyl)-amino]-methyl}-[1,2,4]oxadiazole-5-carboxylic acid [2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide; blood coagulation factor Xa and thrombin inhibitor, anticoagulant; thrombotic disorders: thrombosis, angina pectoris, myocardial infarction, stroke, arteriosclerosis |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103122 Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| 05/01/2008 | US20080103119 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 05/01/2008 | US20080102115 Modified coagulation factor IX polypeptides and use thereof for treatment |
| 05/01/2008 | US20080102065 Erythropoietin receptor extended duration limited agonists |
| 05/01/2008 | US20080102064 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 05/01/2008 | US20080102060 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 05/01/2008 | US20080102058 Stromal cell use |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 04/30/2008 | EP1916260A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 04/30/2008 | EP1916236A1 Amide derivative, pesticide containing such compound and use thereof |
| 04/30/2008 | EP1915993A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 04/30/2008 | EP1736148A4 Medical emulsion of perfluororganic compounds and method for the production thereof |
| 04/30/2008 | EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | EP1165613B1 Melanocortin receptor ligands |
| 04/30/2008 | EP0730657B1 Composition for the in vivo production of therapeutic products |
| 04/30/2008 | DE102006050672A1 New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations |
| 04/30/2008 | DE102006050516A1 New pyrazol-3-one compounds are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful e.g. to treat and/or prophylaxis heart-circulation diseases, heart failure, anemia, chronic kidney diseases and renal failure |
| 04/30/2008 | DE102006050515A1 New substituted dipyridiyl-dihydropyrazolone derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases, heart failure and anemia |
| 04/30/2008 | DE102006050512A1 New substituted dihydropyrazole- and dihydrotriazole derivatives are hypoxia-inducible transcription factor-prolyl-4-hydroxylase inhibitors useful to treat/prevent e.g. cardiovascular diseases, heart-circulation diseases and anemia |
| 04/30/2008 | CN101171027A Use of histones for therapeutic purposes |
| 04/30/2008 | CN101171013A Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 04/30/2008 | CN101168565A Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 04/30/2008 | CN101168016A Oral liquid for cirrhosis ascites and preparation method thereof |
| 04/30/2008 | CN101168013A Orally-administered traditional Chinese medicinal composition for treating leukopenia disease |
| 04/30/2008 | CN101167997A Chinese medicinal herb oral liquid cold tea preparation for preventing and treating acute and chronic damp-heat virus type nephritic edema |
| 04/30/2008 | CN101167989A Medicinal composition for treating internal and external haemorrhage disease and preparation method thereof |
| 04/30/2008 | CN101167914A Traditional Chinese medicine prescription for treating functional metrorrhagia and menorrhagia and preparing method |
| 04/30/2008 | CN101167913A Pus-drawing out medicine powder for externally treating internal illness |
| 04/30/2008 | CN101167910A Oral liquid traditional Chinese medicine for treating cerebral thrombus sequelae |
| 04/30/2008 | CN101167748A Sterilization haemostatic powder |
| 04/30/2008 | CN101167745A Small molecular sugar stable buffer used for blood platelet frozen-dried preservation |
| 04/30/2008 | CN101167719A Gallo catechin and gallate microcapsule granule and preparation technique thereof |
| 04/30/2008 | CN101167708A New use of 6,7-dehydroroyleanone in pharmaceutical |
| 04/30/2008 | CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 04/30/2008 | CN100384825C Benzheterocyclic derivatives |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384489C Hemostatic devices and methods of making same |
| 04/30/2008 | CN100384468C L-methionine as a stabilizer for NESP/EPO in hsa-free formulations |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents |
| 04/29/2008 | US7365088 Indazole-derivatives as factor Xa inhibitors |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | US7364757 Methods of treating vascular disease |
| 04/29/2008 | US7364735 Method for diagnosis and treatment of haemophilia A patients with an inhibitor |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2351341C Collagen hemostatic foam |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2272711C Method for treating renal failure |
| 04/24/2008 | WO2008048981A2 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 04/24/2008 | WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/24/2008 | WO2008046357A1 Aqueous solution containing sodium pyruvate, preparation method and use thereof |
| 04/24/2008 | WO2008046256A1 Haemocoagulase |
| 04/24/2008 | WO2008009638A3 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/24/2008 | WO2008006979B1 Process for preparing diaminophenothiazinium compounds |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents |
| 04/24/2008 | US20080096805 deoxygenated, endotoxin-free and stroma-free transport proteins, incapable of binding with nitric oxide, useful as substitutes for erythrocytes in mammals and for treating disorders where oxygen delivery agents are of benefit |
| 04/24/2008 | US20080095779 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095760 Using fibrinolytic metalloproteinase composition to treat and prevent cardiovascular disorders |
| 04/24/2008 | DE102006048924A1 Acylaminopyrazole Acylaminopyrazole |
| 04/24/2008 | CA2800405A1 Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1913155A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 04/23/2008 | EP1913023A1 Novel anticoagulant polypeptides and complex |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1211305B1 Fat compositions |
| 04/23/2008 | EP1177289B1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166745A Novel thienopyridine compounds, and methods of use thereof |